FDA Drug Shortages

FDA Drug Shortages

FDA knows the major public health consequences that can result from drug shortages. These shortages occur for many reasons including manufacturing and quality problems, delays and discontinuations. When issues are discovered, FDA works closely with the company to address risks involved to prevent harm to patients. FDA also considers the impact a shortage would have on patient care and access and works with the company to restore supplies while also ensuring safety for patients. More information

Drug Shortages Voluntarily Reported by Manufacturers During the Past 2 Weeks:

• Atropine Sulfate Injection
• Fentanyl Citrate (Sublimaze) Injection
• Potassium Chloride Injection
• Rocuronium Bromide Injection

Drug Discontinuation Voluntarily Reported by Manufacturers During the Past 2 Weeks:

• Montelukast Sodium Oral Granules
• Risperidone Orally Disintegrating Tablets, USP